Autolus Therapeutics PLC logo

Autolus Therapeutics PLC

$ 3.34 -0.25 (-6.96%) 04:00 PM EST
P/E:
At Loss
P/B:
1.37
Market Cap:
$ 296.02M
Enterprise V:
$ 127.13M
Volume:
85.15K
Avg Vol (2M):
138.77K
Also Trade In:
Volume:
85.15K
Market Cap $:
296.02M
PE Ratio:
At Loss
Avg Vol (2-Month):
138.77K
Enterprise Value $:
127.13M
PB Ratio:
1.37
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Autolus Therapeutics PLC
NAICS : 325412 SIC : 2834
191 Wood Lane, The MediaWorks, London, GBR, W12 7FP
Description
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Name Current Vs Industry Vs History
Cash-To-Debt 12.58
Equity-to-Asset 0.68
Debt-to-Equity 0.08
Debt-to-EBITDA -0.1
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.7
Distress
Grey
Safe
Beneish M-Score -2.26
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 62.64
9-Day RSI 64.73
14-Day RSI 63.36
6-1 Month Momentum % -32.18
12-1 Month Momentum % -48.78

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.29
Quick Ratio 7.29
Cash Ratio 6.09

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -31.3

Financials (Next Earnings Date:2022-11-03 Est.)

AUTL's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:AUTL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.823
EPS (TTM) ($) -1.85
Beta 1.73
Volatility % 57.25
14-Day RSI 63.36
14-Day ATR ($) 0.279714
20-Day SMA ($) 3.1915
12-1 Month Momentum % -48.78
52-Week Range ($) 1.96 - 7.9
Shares Outstanding (Mil) 90.91

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Autolus Therapeutics PLC Filings

Document Form Filing Date
No Filing Data

Headlines

See More